Our previous data demonstrated that RSK-driven pS473-TRIM28 promotes the transcriptional activation of E2F1 regardless of Rb status (Figure 2), which prompts us to exploit the RSK1–TRIM28–E2F1 axis as a vulnerability in treating Rb-deficient PCa. The gene discussed is E2F1; the disease is posterior cortical atrophy.